Triptans

Sep 19, 2017

New Review Provides an Overview of Triptans in the Treatment of Acute Migraine

Sep 07, 2017

Promius Pharma Presents Positive Results for Phase 2 Study of DFN-02, a Novel Intranasal Formulation of Sumatriptan, at 18th Congress of the International Headache Society

Jun 07, 2017

Promius Pharma Announces Positive Results for Phase 2 Study of DFN-02, a Novel Intranasal Formulation of Sumatriptan

Jun 07, 2017

Promius Pharma to Present Innovative Scientific Results From Migraine Studies at the 59th Annual Scientific Meeting of the American Headache Society

Jun 07, 2017

Grünenthal Enters Agreement with AstraZeneca to Acquire Global Rights to Migraine Treatment Zomig® (Zolmitriptan)